Orchestra BioMed exceeds full enrollment target in BACKBEAT trial
Orchestra BioMed said the BACKBEAT Global pivotal trial of AVIM therapy has exceeded its full enrollment target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.